KROS icon

Keros Therapeutics

129 hedge funds and large institutions have $937M invested in Keros Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 50 increasing their positions, 33 reducing their positions, and 16 closing their positions.

Holders
129
Holders Change
+4
Holders Change %
+3.2%
% of All Funds
2.07%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
20
Increased
50
Reduced
33
Closed
16
Calls
$2.16M
Puts
$4K
Net Calls
+$2.15M
Net Calls Change
-$2.39M
Name Market Value Shares Shares
Change
Shares
Change %
US Bancorp
126
US Bancorp
Minnesota
$2.35K 55
National Bank of Canada
127
National Bank of Canada
Quebec, Canada
$1.28K 30
S
128
SignatureFD
Georgia
$427 10
CAM
129
Cormorant Asset Management
Massachusetts
-100,000 Closed
CC
130
Casdin Capital
New York
-65,000 Closed
HF
131
HRT Financial
New York
-21,222 Closed
Bank of Montreal
132
Bank of Montreal
Ontario, Canada
-19,400 Closed
HS
133
HighVista Strategies
Massachusetts
-18,616 Closed
MIH
134
Meitav Investment House
Israel
-17,475 Closed
ECM
135
ExodusPoint Capital Management
New York
-11,823 Closed
BC
136
Brookfield Corp
Ontario, Canada
-9,014 Closed
DTL
137
Dynamic Technology Lab
Singapore
-8,760 Closed
ProShare Advisors
138
ProShare Advisors
Maryland
-4,753 Closed
SFG
139
SVB Financial Group
Texas
-4,653 Closed
BC
140
BIT Capital
Germany
-1,330 Closed
ZIG
141
Zullo Investment Group
Pennsylvania
-300 Closed
Simplex Trading
142
Simplex Trading
Illinois
-53 Closed
Rockefeller Capital Management
143
Rockefeller Capital Management
New York
-41 Closed
LC
144
Lindbrook Capital
California
-38 Closed
Group One Trading
145
Group One Trading
Illinois
CG
146
Cutler Group
California
C
147
Covestor
United Kingdom
$0 3
CFGS
148
Concourse Financial Group Securities
Alabama